Date & Time of Session - 4/3/26 - from 12:00 - 1:00PM

Overview
Kawasaki Disease is an acute, self-limiting vasculitis and a leading cause of acquired heart disease in pediatric patients. Delayed or missed diagnosis of Kawasaki Disease carries significant risk, with coronary artery aneurysms developing in approximately 25% of untreated patients. Early recognition and initiation of therapy reduce this risk to less than 5%, emphasizing the importance of timely intervention. Pharmacists play a critical role in the management of Kawasaki disease by ensuring rapid initiation of evidence-based therapies, optimizing medication regimens, minimizing adverse effects, and providing guideline-driven recommendations for both acute treatment and long-term management of cardiovascular sequelae.

Objectives
Upon completion of this activity, participants will be able to:
1. Describe the pathophysiology, diagnostic criteria, and treatment of Kawasaki Disease 
2. Evaluate existing literature and guideline recommendations regarding first and second line treatment options of Kawasaki Disease
3. Discuss long-term follow up and pharmacologic management of patients with a history of Kawasaki Disease

    Target Audience
    Pharmacists, residents, and students

    Special Services
    If you require special assistance to attend this event, please call Megan Russell at (304) 550-0896.

    Speaker:
    Hannah Shouse, PharmD
    PGY2 Pediatric Pharmacy Resident
    UK College of Pharmacy - Lexington, Kentucky

    Session date: 
    04/03/2026 - 12:00pm EDT to 06/01/2026 - 11:59pm EDT
    Add to calendar: 
    • 1.00 ACPE

      In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.

      This knowledge-based activity will award 1.00 contact hour(s) (0.100 CEUs) of continuing pharmacy education credit in states that recognize ACPE providers. Course JA-UAN Number: JA0000312-0000-25-046-L01-P

    • 1.00 Participation
      UK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.
    Please login or register to take this course.
    Faculty List: 
    Speaker(s)

    Hannah Shouse, Hannah Shouse, PharmD, PGY2 Pediatric Pharmacy Resident

    has no relevant financial relationships to disclose at this time.